Summit Therapeutics shares rose sharply Friday morning, a day after the company said its developmental lung cancer drug was ...

One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher Scientific over the past 10 years ...

By Patrick Wingrove (Reuters) -One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher ...

The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 ...

The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making ...

The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 ...

The U.S. Drug Enforcement Administration (DEA) on Friday warned of an increase in illegal online pharmacies selling ...

Atsena Therapeutics, a Durham company developing gene therapies to treat genetic causes of blindness, has received another ...

BMO Capital Markets analyst Evan Seigerman called it “another positive indication” for Eli Lilly, whose top-selling diabetes ...

Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...

A Colorado-based candy shop issued a recall after discovering one of its products caused an allergic reaction. The Food and ...

The approval came days before the FDA’s expected deadline and makes this the only PD-1 inhibitor approved for resectable ...